BioSpace News Archive

Policy

Eisai, Biogen Launch Rolling BLA for Subcutaneous Alzheimer’s Therapy Leqembi

After missing their initial target in March 2024, Eisai and Biogen have initiated a rolling BLA for a subcutaneous maintenance formulation of Leqembi, which could offer a more convenient dosing schedule for Alzheimer’s disease patients.

May 15, 2024
·
2 min read
·
Tristan Manalac
Business

Winners and Losers in Biopharma’s Q1 2024 Earnings Season

The weight-loss drug bonanza continued in the first quarter of 2024 for Novo Nordisk and Eli Lilly, as Amgen also posted strong results, while Biogen and BMS struggled early in the financial year.

May 15, 2024
·
5 min read
·
Ben Hargreaves
Job Trends

5 Top Companies Hiring Software Development Jobs

Looking for software development jobs in the biopharma industry? Check out these five top companies hiring life sciences professionals like you.

May 15, 2024
·
1 min read
·
Angela Gabriel
Policy

FDA Delays Review by Three Months for Ascendis’ Hypoparathyroidism Therapy

Following an initial rejection in 2023, Ascendis Pharma on Tuesday said it faces another regulatory bump in the road for TransCon PTH with a three-month delay in the ongoing FDA review.

May 15, 2024
·
2 min read
·
Tristan Manalac
Sands Capital Launches $555M Life Sciences Fund Focusing on Private Companies

With more than half a billion dollars in the new life sciences fund, Sands Capital is looking to finance private companies working to transform the diagnosis and treatment of diseases with large unmet medical needs.

May 15, 2024
·
2 min read
·
Tristan Manalac
Drug Development

Uniquity Bio Emerges from Stealth with $300M from Blackstone, Targets Asthma and COPD

Armed with a $300 million commitment from Blackstone Life Sciences and a former Merck monoclonal antibody, Uniquity Bio is starting Phase II clinical trials in asthma and chronic obstructive pulmonary disease.

May 15, 2024
·
2 min read
·
Kate Goodwin
Deals

Novo Acquires Majority Stake in Austrian Life Sciences Tools Company

While the FTC continues to review its $16.5 billion buy of Catalent, Novo Holdings announced Wednesday it has acquired a majority stake in Single Use Support, an Austrian life sciences tools company.

May 15, 2024
·
2 min read
·
Tristan Manalac
Career Advice

Ageism Isn’t Always the Reason Older, Younger Workers Aren’t Hired

While biopharma professionals cited age discrimination as an issue in a new BioSpace report, it’s not the only factor affecting older and younger people’s job searches.

May 15, 2024
·
6 min read
·
Angela Gabriel
Opinion: How to Make Today’s Clinical Research More Efficient

With medicine becoming more specialized and clinical trial protocols increasingly complex, we need to think about how to drive efficiencies to overcome these challenges and keep up the pace of research.

May 15, 2024
·
5 min read
Business

Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of Directors

Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced the appointment of Aleksandra Rizo, M.D., Ph.D., to its Board of Directors.

May 15, 2024
·
6 min read